Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

Core Points - Pharming Group N.V. will hold its 2025 Annual General Meeting of Shareholders on June 11, 2025, at 14:00 CEST [1] - Dr. Elaine Sullivan is nominated for appointment as a new Non-Executive Director for a four-year term [2] - The AGM agenda includes reappointments of existing Non-Executive Directors, the proposal to reappoint Deloitte Accountants B.V. as the external auditor for 2025, and the renewal of share issuance and repurchase authorizations [3] Company Profile - Pharming Group N.V. is a global biopharmaceutical company focused on developing innovative medicines for patients with rare and life-threatening diseases [9] - The company is headquartered in Leiden, the Netherlands, and operates in over 30 markets worldwide [9] - Pharming's portfolio includes both small molecules and biologics [9] Director Profile - Dr. Elaine Sullivan has extensive experience in the pharmaceutical and biotech industry, with a successful track record in drug development and business [5] - She has served as a Non-Executive Director at Zealand Pharma A/S and hVIVO, and has held leadership roles at Eli Lilly and AstraZeneca [6][7] - Dr. Sullivan holds a PhD in Molecular Virology and a BSc in Molecular Biology [8]